Trial intelligence / Profile preview

Randomized, double-blind, placebo-controlled phase 3 trial of diltiazem hydrochloride cream for anal fissure pain

2008-005172-26Phase 3Completed

Sponsor
SLA Pharma
Start
Jul 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of diltiazem in anal fissure (3 arms), sponsored by SLA Pharma. Primary endpoint: Change in pain associated with anal fissure. Started Jul 2010; status: completed.

02

Drugs

diltiazem
03

Conditions

anal fissure

Beyond the preview

Go deeper on 2008-005172-26.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-005172-26.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call